Literature DB >> 1698986

CD5 positive B lymphocytes in seronegative juvenile arthritis.

A Martini1, M Massa, F De Benedetti, S Viola, G Neirotti, R G Burgio.   

Abstract

We investigated the levels of circulating CD5+ B cells in 43 patients with seronegative, HLA-B27 negative juvenile arthritis, 7 patients with juvenile dermatomyositis (DM) and 16 children with systemic lupus erythematosus (SLE). We found that CD5+ B cell levels were high in juvenile arthritis (p less than 0.01), normal in juvenile DM and decreased in SLE (p less than 0.01) compared to 33 age matched controls. In juvenile arthritis, the increase of CD5+ B cells appeared to be independent of discuss activity and was present in all the onset types except in a subset of patient with late onset pauciarthritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698986

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Authors:  Claudia Macaubas; Khoa Nguyen; Chetan Deshpande; Carolyn Phillips; Ariana Peck; Tzielan Lee; Jane L Park; Christy Sandborg; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-10-29       Impact factor: 3.969

2.  Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis.

Authors:  C Faber; H Morbach; S K Singh; H J Girschick
Journal:  Ann Rheum Dis       Date:  2006-02-27       Impact factor: 19.103

3.  Low molecular weight IgM and CD5 B lymphocytes in rheumatoid arthritis.

Authors:  H Xu; R Geddes; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

Review 4.  B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

Authors:  Rita A Moura; João Eurico Fonseca
Journal:  Front Med (Lausanne)       Date:  2022-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.